Stay updated with breaking news from Gap Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Washington State University researchers have developed a new bioreactor prototype that can rapidly grow white blood cells, promising an advance in the availability of immunotherapy as a cancer treatment.
A bioreactor developed by WSU researchers to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy.
<p>A new tool to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy, a promising therapy which harnesses the power of the body’s immune response to target cancer cells. Washington State University researchers have developed a minifridge-sized bioreactor that is able to manufacture the cells, called T cells, at 95% of the maximum growth rate – about 30% faster than current technologies. They developed it using T cells from cattle and anticipate it will perform similarly on human cells.</p>
European Investment Bank invests Ksh. 40 million to support efforts in solid waste management in Kisumu County
The Bridging The Gap 10 Mile Race takes place in Duluth on Saturday, October 7th at 8 a.m. Registration is still open until Friday, October 6th at 5:30 p.m.